weeks old) were procured from The Jackson Laboratory. All mice were
maintained at Stanford University according to the Public Health Service
Policy for “Humane Care and Use of Laboratory Animals”
following a protocol approved by Stanford University Administrative
Panel on Laboratory Animal Care (APLAC-33709). Mice were immunized
via subcutaneous injection of 10 μg of antigen with the exception
of SΔC-Fer dosing and longevity studies in which animals were
immunized with either 0.1, 1, 10, or 20 μg as specified in
with 10 μg of Quil-A (InVivogen) and 10 μg of monophosphoryl
lipid A (InVivogen) diluted in 1× Dulbecco’s phosphate-buffered
saline (DPBS) (Gibco) in a total volume of 100 μL per injection.
Mice were immunized at day 0 and day 21. Serum was collected at days
0, 21, and 28 and processed using Sarstedt serum collection tubes.
Day 0 serum was analyzed for both ELISA binding and lentiviral neutralization
and showed no evidence of binding or neutralizing activity (data not
shown).